Literature DB >> 2233977

Coelomomyces psorophorae var tasmaniensis Couch + Laird (1988) (Coelomomycetaeceae: Blastocladiales), a fungal pathogen of the mosquito Aedes australis. II: Nuclear changes during meiospore formation.

F C Buchanan1, J S Pillai.   

Abstract

The presence of synaptonemal complexes were checked in dividing chromosomes as evidence for meiotic division in germinating sporangia. Continuous urografin gradients were used to separate out the various phases of germinating sporangia, the nuclei were removed and embedded for ultrastructural studies. Meiotic inhibitors were applied to germinating sporangia to retard meiotic division to highlight the synaptonemal complexes. At an early phase of sporangial differentiation dividing nuclei developed with synaptonemal complexes. Meiotic inhibitors and stimulators may be used to control sporangial germination for an induction of a high meiospore count. This may be of crucial importance in the utilization of Coelomomyces spp. as a biological control agent of mosquito species.

Entities:  

Mesh:

Year:  1990        PMID: 2233977     DOI: 10.1007/bf02277298

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  4 in total

1.  Life history of Coelomomyces psorophorae.

Authors:  H C Whisler; S L Zebold; J A Shemanchuk
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  A glass bead treatment facilitating the fixation and infiltration of yeast and other refractory cells for electron microscopy.

Authors:  L W Olson; U M Edén
Journal:  Protoplasma       Date:  1977       Impact factor: 3.356

3.  Phylogenetic implications of the microbody-lipid globule complex in zoosporic fungi.

Authors:  M J Powell
Journal:  Biosystems       Date:  1978-04       Impact factor: 1.973

4.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.